Isavuconazole dosing in Asian patients with invasive mould infections: is there a role for therapeutic drug monitoring ?

Yvonne Fu Zi Chan, Yvonne Peijun Zhou,Ban Hock Tan,Candice Yuen Yue Chan,Benjamin Pei Zhi Cherng,Yii Ean Teh, Gee Chuan Wong,Andrea Lay Hoon Kwa, Tze Peng Lim, Kelvin Kau Kiat Goh, Farah Iffah Binte Zulkifli,Jasmine Shimin Chung

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS(2023)

引用 0|浏览5
暂无评分
摘要
The regioisomers of the anandamide-acting drug LY2183240 exhibited specific potent and competitive inhibitory activities against class C β-lactamases. More explicitly, the 1,5- and 2,5-regioisomers inhibited AmpC from Enterobacter hormaechei (formerly Enterobacter cloacae) with inhibitor binding affinity values of 1.8 µM and 2.45 µM, respectively. Structural molecular modelling studies revealed the interaction of the regioisomers with the relevant residues of the catalytic site of cephalosporinase from E. hormaechei P99, which included Tyr150, Lys315 and Thr316.
更多
查看译文
关键词
invasive mould infections,therapeutic drug monitoring,asian patients
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要